In this episode, Scott Becker discusses Bitcoin’s drop from its recent peak near $126,000 to the mid $60,000 range as risk sentiment weakens, leveraged bets unwind, and the government signals no crypto bailouts.

In this episode, Scott Becker break down Peloton’s disappointing earnings report with revenue falling short of expectations and weak future guidance, continuing a sharp multiyear decline in sales and stock performance.

In this episode, Scott Becker shares quick takes on Oracle, Bitcoin, Lululemon, and Lucid Motors, breaking down steep year to date and one year declines and what is driving the pullback in each.

In this episode, Scott Becker walks through the year to date performance of several closely followed stocks including Intel, Coca-Cola, Bank of America, UnitedHealth Group, and Palantir.

In this episode, Scott Becker outlines 5 troubling signals in the economy, including sharply lower job creation, major media layoffs, and more.

In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods LLP, shares how private equity investing in healthcare is evolving, from increased selectivity and creative deal structures to operational value creation and execution risk.

In this episode, Scott Becker reflects on his personal experience investing in private equity and venture capital, comparing expectations with reality and exploring the idea of being the dog who caught the car.

In this episode, Scott Becker reviews the YTD performance of the largest private equity and alternative asset managers, ranking Carlyle, Apollo, Blackstone, TPG, and KKR from best to worst.

In this episode, Chris Lacy, President at Priority Search Management, joins Scott Becker to share practical insights on hiring, onboarding, and why companies often overlook the critical “missing middle” below the executive level.

In this episode, Scott Becker breaks down the year to date performance of the Magnificent 7, highlighting gains and losses across Meta, Tesla, Apple, Microsoft, and others.